Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

The Effect of Childhood Obesity or Sarcopenic Obesity on Metabolic Syndrome Risk in Adolescence: The Ewha Birth and Growth Study

View through CrossRef
The prevalence of obesity and metabolic syndrome (MetS) in the pediatric population has increased globally. We evaluated the impact of childhood obesity and sarcopenic obesity on the risk of MetS in adolescence using the Ewha Birth and Growth Cohort study data. In this study, we analyzed data from 227 participants who were followed up at the ages of 7–9 and 13–15 years. Overweight and obesity were defined as a body mass index of the 85th percentile or higher based on national growth charts, and sarcopenic obesity was defined using body composition data. Metabolic diseases in adolescence were identified by calculating the pediatric simple metabolic syndrome score (PsiMS), continuous metabolic syndrome score (cMetS), and single-point insulin sensitivity estimator (SPISE) as MetS indices. The prevalence of overweight was approximately 15% at both 7–9 and 13–15 years old, and that of sarcopenic obesity (7–9 years old) was 19.5%. Boys aged 13–15 years had a significantly larger waist circumference (WC) and higher systolic blood pressure (SBP) than girls. The MetS indices (PsiMS, cMetS, and SPISE) showed no significant differences by gender. Overweight and sarcopenic obese people have a higher overall risk of MetS components than normal people. The overweight group had a significantly higher prevalence of PsiMS and cMetS than the normal group, while the SPISE was significantly lower and the MetS indicator was worse in the overweight group than in the normal group. Similar results were obtained in the group with sarcopenic obesity. Both overweight and sarcopenic obesity remained significantly associated with MetS indicators, even after adjusting for covariates. Furthermore, metabolic health assessed by the cMetS in adolescence was affected not only by childhood overweight but also by adolescence, which showed an interaction effect. The results of this study emphasize the importance and need for early detection of childhood obesity and effective public health interventions.
Title: The Effect of Childhood Obesity or Sarcopenic Obesity on Metabolic Syndrome Risk in Adolescence: The Ewha Birth and Growth Study
Description:
The prevalence of obesity and metabolic syndrome (MetS) in the pediatric population has increased globally.
We evaluated the impact of childhood obesity and sarcopenic obesity on the risk of MetS in adolescence using the Ewha Birth and Growth Cohort study data.
In this study, we analyzed data from 227 participants who were followed up at the ages of 7–9 and 13–15 years.
Overweight and obesity were defined as a body mass index of the 85th percentile or higher based on national growth charts, and sarcopenic obesity was defined using body composition data.
Metabolic diseases in adolescence were identified by calculating the pediatric simple metabolic syndrome score (PsiMS), continuous metabolic syndrome score (cMetS), and single-point insulin sensitivity estimator (SPISE) as MetS indices.
The prevalence of overweight was approximately 15% at both 7–9 and 13–15 years old, and that of sarcopenic obesity (7–9 years old) was 19.
5%.
Boys aged 13–15 years had a significantly larger waist circumference (WC) and higher systolic blood pressure (SBP) than girls.
The MetS indices (PsiMS, cMetS, and SPISE) showed no significant differences by gender.
Overweight and sarcopenic obese people have a higher overall risk of MetS components than normal people.
The overweight group had a significantly higher prevalence of PsiMS and cMetS than the normal group, while the SPISE was significantly lower and the MetS indicator was worse in the overweight group than in the normal group.
Similar results were obtained in the group with sarcopenic obesity.
Both overweight and sarcopenic obesity remained significantly associated with MetS indicators, even after adjusting for covariates.
Furthermore, metabolic health assessed by the cMetS in adolescence was affected not only by childhood overweight but also by adolescence, which showed an interaction effect.
The results of this study emphasize the importance and need for early detection of childhood obesity and effective public health interventions.

Related Results

Sarcopenic Obesity in Cancer Patients: Focus on Pathogenesis
Sarcopenic Obesity in Cancer Patients: Focus on Pathogenesis
Introduction: Sarcopenic obesity is an emerging problem in cancer patients. However, this is often difficult to diagnose without the measurement of body composition. Sarcopenic obe...
Adiponectin and phase angle in the assessment of sarcopenia in Crohn’s disease: beyond muscle mass
Adiponectin and phase angle in the assessment of sarcopenia in Crohn’s disease: beyond muscle mass
Introduction Sarcopenia is a common and clinically relevant complication of Crohn’s disease (CD), reflecting the cross-link among chronic inflammation, malnutri...
Determinants of Metabolic Syndrome among Malaysian Government Employees
Determinants of Metabolic Syndrome among Malaysian Government Employees
Introduction: The metabolic syndrome comprises a collection of cardiovascular disease risks, which has been demonstrated to predict type 2 diabetes mellitus and cardiovascular dise...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
The Effect of Hemodialysis Treatment on Sarcopenia in Patients Newly Starting Hemodialysis
The Effect of Hemodialysis Treatment on Sarcopenia in Patients Newly Starting Hemodialysis
ABSTRACT Background The research aimed to establish sarcopenia occurrence rates among patients beginning hemodialysis tre...
The discriminative role of angiopoietin-like protein-3 for metabolic syndrome in polycystic ovary syndrome
The discriminative role of angiopoietin-like protein-3 for metabolic syndrome in polycystic ovary syndrome
SUMMARY OBJECTIVE: Patients with polycystic ovary syndrome face an increased risk of developing metabolic syndrome. Identifying biomarkers that can detect metabolic syndrome in po...
Intrinsic Motoneuron Excitability Differentiates Sarcopenic, Non-Sarcopenic, and Athletic Ageing Phenotypes
Intrinsic Motoneuron Excitability Differentiates Sarcopenic, Non-Sarcopenic, and Athletic Ageing Phenotypes
Background: The mechanisms underlying sarcopenia-related physical decline remain poorly understood, particularly with respect to neural contributions. Muscle atrophy has traditiona...

Back to Top